NASDAQ Composite opens in less than two hours and Gilead Sciences’s pre-market value is already 2.19% up.
The last session, NASDAQ Composite ended with Gilead Sciences rising 1.49% to $63.33. NASDAQ Composite dropped 0.87% to $12,998.50, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session.
Gilead Sciences’s last close was $63.04, 35.75% under its 52-week high of $85.97.
Gilead Sciences’s Sales
Gilead Sciences’s sales growth is 10% for the ongoing quarter and 10.3% for the next. The company’s growth estimates for the present quarter and the next is 32.3% and 4.8%, respectively.
Gilead Sciences’s Revenue
Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 23.15B for the twelve trailing months.
Gilead Sciences’s Stock Yearly Top and Bottom Value
Gilead Sciences’s stock is valued at $63.33 at 08:18 EST, way below its 52-week high of $85.97 and way higher than its 52-week low of $56.56.
Gilead Sciences’s Moving Average
Gilead Sciences’s worth is above its 50-day moving average of $59.74 and below its 200-day moving average of $65.03.
Gilead Sciences’s last day, last week, and last month’s average volatility was 0.83%, 1.60%, and 0.15%, respectively.
Gilead Sciences’s last day, last week, and last month’s high and low average amplitude percentage was 1.44%, 2.69%, and 1.79%, respectively.